ANPEP and obesity disorder: Anti‐inflammatory and antiobesity effects of carvacrol derivatives (CD1‐3) were investigated in vitro (3T3‐L1, WJ‐MSCs, and THP‐1 cell lines) by assessing the expression of obesity‐related proteins and reducing TNF‐α expression, respectively.